Integrated Cell Manipulation Platform Coupled with the Single-probe for Mass Spectrometry Analysis of Drugs and Metabolites in Single Suspension Cells
June 21st, 2019
6.3K views
An integrated cell manipulation platform is developed for use in conjunction with a single-probe mass spectrometry setup for the on-line analysis of individual suspension cells under ambient conditions.
Overview
This article presents an integrated platform combining single-probe single cell mass spectrometry (SCMS) with a cell manipulation system, enabling rapid and sensitive analysis of individual floating cells directly from solution. The method allows for minimal sample preparation and preserves cells in a near-native environment, facilitating the study of cellular heterogeneity and the detection of intracellular metabolites, lipids, and drugs at the single-cell level. The approach is applicable to patient-derived samples, supporting potential applications in disease biology and personalized medicine.
Key Study Components
Area of Science
- Analytical Chemistry
- Single Cell Analysis
- Mass Spectrometry
- Cell Biology
Background
- Traditional SCMS techniques were limited to immobilized cells, restricting the types of cells that could be analyzed.
- Analyzing cells in solution allows for the study of cells in a more native state, including those derived from patient samples.
- Cellular heterogeneity is important for understanding disease mechanisms and drug responses.
- Minimizing sample preparation reduces potential artifacts and preserves cellular integrity.
Purpose of Study
- To develop a platform for SCMS analysis of individual floating cells from solution.
- To integrate a cell manipulation system for targeted cell selection and transfer.
- To enable rapid, online analysis of cellular constituents under ambient conditions.
Methods Used
- Fabrication of tapered glass probes for sampling and cell selection.
- Integration of a cell manipulation system (similar to those used in IVF) with the single-probe SCMS setup.
- Use of an inverted microscope and microinjector for precise cell capture and transfer.
- Online lysis and mass spectrometry analysis of individual cells using nanoelectrospray ionization.
- Application of the method to K-562 cells and detection of cellular lipids and drug compounds.
Main Results
- Successful capture and transfer of individual floating cells for SCMS analysis.
- Detection of key cellular lipid peaks (e.g., PC 34:4, PC 36:4, PC 38:5) confirming effective cell lysis and content analysis.
- Identification of drug compounds (Gemcitabine, Taxol, OSW1) in treated K-562 cells at the single-cell level.
- Demonstration that the method can analyze cells from patient-derived samples with minimal preparation.
Conclusions
- The integrated platform enables sensitive, rapid SCMS analysis of individual cells in solution.
- This approach facilitates the study of cellular heterogeneity and drug responses in a near-native environment.
- The method holds promise for applications in disease biology, personalized medicine, and liquid biopsy analysis.
Frequently Asked Questions
What is the main advantage of integrating single-probe SCMS with a cell manipulation system?
This integration allows for the targeted capture and analysis of individual floating cells directly from solution, enabling studies on a wider variety of cell types, including those from patient samples, with minimal preparation.
How does this method preserve the native state of cells?
By analyzing cells directly from solution with little to no sample preparation, the method maintains cells in a near-native environment, reducing artifacts and preserving physiological relevance.
What types of cellular components can be detected using this technique?
The method enables detection of a broad range of cellular species, including lipids, metabolites, and drug compounds, at the single-cell level.
Can this technique be applied to clinical samples?
Yes, the platform is suitable for analyzing patient-derived cells from body fluids such as blood, urine, and saliva, supporting applications in disease biology and personalized medicine.
What are the key steps in preparing the single-probe and cell selection devices?
Key steps include pulling and tapering glass tubing to create sharp probe tips, bending the probes for optimal positioning, and integrating them with a microinjector and microscope for precise cell manipulation.
How is cell lysis achieved for mass spectrometry analysis?
Cells are transferred to the single-probe tip, where microscale lysis occurs immediately before mass spectrometry analysis, ensuring rapid and efficient detection of cellular contents.
What safety precautions are recommended when performing this method?
Researchers should wear appropriate personal protective equipment, including lab coats, gloves, and eye protection, especially when handling glass components.
Executive Industry Relevance
The integration of single-probe mass spectrometry with a cell manipulation platform enables direct, quantitative analysis of drugs and metabolites in individual suspension cells from patient-derived samples. This approach addresses the challenge of studying cellular heterogeneity and drug response in a near-native environment, supporting predictive confidence in early discovery and translational research. The platform's minimal sample preparation and compatibility with liquid biopsies position it as a valuable asset for risk-adjusted portfolio decisions in disease biology and personalized medicine.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of therapeutic hypotheses by quantifying intracellular drug and metabolite levels in single cells.
- Supports biological de-risking by revealing cellular heterogeneity and functional target engagement in patient-derived samples.
- Facilitates predictive confidence and triage of targets based on direct molecular readouts from disease-relevant cells.
Screening & Assay Development
- Prepares validated single-cell systems for downstream compound screening and mechanistic studies.
- Delivers reproducible, quantitative mass spectrometry outputs for assay standardization and benchmarking.
- Enables scalable, high-content analysis of drug uptake and metabolism at the single-cell level.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by enabling analysis of patient-isolated cells from body fluids.
- Provides continuity from discovery through preclinical validation by supporting liquid biopsy and disease-state profiling.
- De-risks advancement decisions by offering direct evidence of drug action in clinically relevant cell populations.
Pipeline & Workflow Integration
This platform bridges early discovery, lead identification, and translational research by enabling direct, quantitative analysis of single suspension cells from clinical samples.
- Discovery Biology: Supports hypothesis testing and pathway clarification through single-cell drug and metabolite profiling.
- Screening: Provides assay-ready, reproducible systems for evaluating compound effects in heterogeneous cell populations.
- Analytics: Delivers high-resolution, quantitative mass spectrometry data for comparative analysis across conditions.
- Translational Research: Connects discovery outputs to preclinical and clinical biomarker strategies using patient-derived cells.
- Enterprise Reuse: Establishes a reusable analytical capability for diverse disease models and sample types.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and target validation by resolving cellular heterogeneity at the molecular level.
- Operational Value: Streamlines workflows with minimal sample preparation and robust, reproducible outputs.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing actionable data from clinically relevant samples.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of programs based on direct evidence from patient-derived cells.
Implementation Considerations
- Requires expertise in single-cell manipulation, mass spectrometry, and data interpretation.
- Demands specialized instrumentation, including microinjectors, inverted microscopes, and high-resolution mass spectrometers.
- Necessitates cross-team standardization of sample handling and analytical protocols.
- Adaptable to various cell types and body fluids, but may require optimization for specific disease models.
- Practical limitations include throughput and the need for precise cell selection and transfer.
Biopharma FAQs
Why does null hypothesis testing matter for single-cell drug quantification?
Null hypothesis testing enables teams to rigorously determine whether observed differences in drug or metabolite levels across single cells are statistically significant, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit the cell selection and transfer workflow?
By isolating individual cells from solution and transferring them directly to the single-probe tip, the workflow ensures that each analysis reflects a controlled, independent variable, minimizing confounding factors from the surrounding matrix.
What do quantitative dependent variable measurements enable in SCMS analysis?
Quantitative measurements of intracellular drugs and metabolites at the single-cell level enable precise comparison of treatment effects, cellular heterogeneity, and mechanistic responses, informing go/no-go decisions in R&D pipelines.
Why are replication requirements critical for cross-functional SCMS studies?
Replication ensures that observed molecular profiles and drug responses are reproducible across different cells and experiments, facilitating cross-functional collaboration and confidence in translational findings.
What statistical analysis capabilities are required before implementing single-cell MS workflows?
Robust statistical tools are needed to analyze high-dimensional, quantitative mass spectrometry data, assess variability, and validate findings across single-cell replicates, ensuring reliable interpretation for portfolio decision-making.
Chapters in this video
0:04
Title
0:42
Glass Cell-Selection Probe Fabrication and Integrated Cell Manipulation Platform Assembly
2:32
Couple the ICMP with a Single-Probe Setup and Suspended Cell Sample Preparation
3:58
Perform SCMS Measurements Using the ICMP/Single-probe Setup
5:57
Results: Integrated Cell Manipulation Platform Testing of Single Suspension Cells
7:07
Conclusion
